Remove 2013 Remove Clinical Trials Remove DEA Remove Hemp
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2013 Sep;36(9):2530-5.

article thumbnail

Buzzes & Bummers: 2018 Was a Wild Ride in the World of Cannabis

SpeedWeed

And then you scroll a little further down and discover that the new Farm Bill is going to legalize hemp farming in the United States for the first time in eighty years ( huzzah!). RELATED STORY. The Top 10 Cannabis Stories of 2018. Or that Big Tobacco just invested $2.4 billion dollars in the weed business ( f**k!).